GGrantIndex
Sort

64,565 grants matching drug discovery

High-Throughput Electrokinetic Fractionation and Analysis of Extracellular RNA Nano-Carriers

$943,995
Hsueh-Chia Chang · University Of Notre Dame · UH3 · FY2021 · CA

High-Throughput Electrokinetic Fractionation and Analysis of Extracellular RNA Nano-Carriers

$943,995
Hsueh-Chia Chang · University Of Notre Dame · UH3 · FY2022 · CA

Genetic Determinants of Epilepsy in Murine Systems

$943,906
Tristan T Sands · Columbia University Health Sciences · R01 · FY2025 · NS

Optimization and evaluation of novel benzimidazoles for the treatment of Alzheimer's Disease

$943,599
Kevin Hodgetts · Brigham And Women'S Hospital · U01 · FY2022 · AG

Spectrally resolved tomographic small-animal fluorescence imager

$942,932
Dylan Bulseco · Cambridge Research And Instrumentation · R44 · FY2010 · CA

Bay Area Cancer Target Discovery and Development

$942,785
Michael T McManus · University Of California, San Francisco · U01 · FY2024 · CA

Rapid sensitive low-cost test for resistant microbes causing hospital infections

$942,482
Sadanand Gite · First Light Diagnostics , Inc. · R44 · FY2013 · AI

Development of a Blood-based Test for Identifying Synucleinopathy in Patients with Dementia

$942,163
Erez Eitan · Neurodex Inc · R44 · FY2024 · NS

Preclinical discovery of novel farnesyltransferase inhibitors for the treatment of Alzheimer's disease and related tauopathies

$942,121
Steven H Olson · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2022 · AG

Strain-Independent Therapeutic Antibodies for Influenza

$941,551
Lawrence Michael Kauvar · Trellis Bioscience, Inc. · R44 · FY2015 · AI

Data Coordination Center for PDX Net

$941,498
Jeffrey Hsu-Min Chuang · Jackson Laboratory · U24 · FY2019 · CA

The UIUC Neuroproteomics Center on Cell-Cell Signaling

$941,481
Jonathan V. Sweedler · University Of Illinois At Urbana-Champaign · P30 · FY2011 · DA

Novel rifamycins to improve cure rates and shorten treatment of M. abscessus lung disease

$941,394
Thomas Dick · Hackensack University Medical Center · U19 · FY2025 · AI

Expanding small molecule functional metagenomics through shuttle BAC expression i

$941,322
Chengcang Charles Wu · Intact Genomics, Inc. · R44 · FY2014 · AI

The hCNS-HIV/ARV assay system, a platform utilizing human iPSC-neurons/-microglia/-astrocytes to test HIV/AIDS therapeutics for neurotoxicity related to HIV-associated cognitive disroder (HAND)

$940,992
Patrick M McDonough · Vala Sciences, Inc. · R44 · FY2022 · MH

Development of novel proteins synthesis inhibitors for MDR tuberculosis

$940,979
Richard Edward Lee · St. Jude Children'S Research Hospital · R01 · FY2011 · AI

Establishment of a First-in-Class Biocompatible and Efficient Cryopreservation Technology Platform for the Next Generation of Cell-Based Therapeutics in Regenerative Medicine and Drug Discovery

$940,821
Xu Han · Cryocrate, Llc · R44 · FY2024 · OD

D-ISN: TRACK 1: Collaborative Research: An Interdisciplinary Approach to Understanding, Modeling, and Disrupting Drug and Counterfeit Illicit Supply Chains

$940,768
Louise Shelley · George Mason University · · FY2020 · ENG

Translating genomic discoveries to improved outcomes for high risk acute leukemia

$940,706
Charles G. Mullighan · St. Jude Children'S Research Hospital · R35 · FY2020 · CA

Genetic Determinants of Epilepsy in Murine Systems

$940,521
Tristan T Sands · Columbia University Health Sciences · R01 · FY2024 · NS

Identifying Genetic Variants Associated with Opioid Overdose Mortality

$940,438
Elliot C Nelson · Washington University · R01 · FY2021 · DA

CANCER DRUG DISCOVERY: CELL CYCLE CONTROL TARGETS

$940,402
University Of South Florida · P01 · FY2003 · CA

Data Generation Core - Neuron and Glial Cellular Signatures from Normal and Diseased iPS Cells

$940,394
Leslie Michels Thompson · University Of California-Irvine · U54 · FY2014 · NS

High throughput infrastructure for reaction screening and bioassays

$940,354
Robert Graham Cooks · Purdue University · UG3 · FY2023 · TR

Hybrid Molecules Designed to Enhance Antibiotic Activity

$939,605
George E Wright · Glsynthesis, Inc. · R44 · FY2007 · AI